Janus Henderson Investors US’s Bristol-Myers Squibb BMY Stock Holding History

Janus Henderson Investors US’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$276M	Sell	5,075,397 -14,748,620	-74%	-$809M	0.23%	126
2016 Q4	$1.16B	Sell	19,824,017 -2,729,508	-12%	-$149M	0.97%	9
2016 Q3	$1.22B	Buy	22,553,525 +615,986	+3%	+$39.6M	1.03%	11
2016 Q2	$1.61B	Buy	21,937,539 +1,094,167	+5%	+$77.3M	1.37%	4
2016 Q1	$1.33B	Buy	20,843,372 +2,667,342	+15%	+$168M	1.15%	11
2015 Q4	$1.25B	Sell	18,176,030 -2,762,356	-13%	-$183M	1.07%	11
2015 Q3	$1.24B	Buy	20,938,386 +4,306,094	+26%	+$273M	1.11%	9
2015 Q2	$1.11B	Buy	16,632,292 +3,676,403	+28%	+$242M	0.91%	15
2015 Q1	$836M	Buy	12,955,889 +716,909	+6%	+$44.9M	0.69%	23
2014 Q4	$722M	Buy	12,238,980 +3,539,323	+41%	+$200M	0.62%	25
2014 Q3	$445M	Buy	8,699,657 +4,859,992	+127%	+$243M	0.41%	57
2014 Q2	$186M	Sell	3,839,665 -3,328,125	-46%	-$164M	0.17%	165
2014 Q1	$372M	Buy	7,167,790 +712,451	+11%	+$37.9M	0.35%	70
2013 Q4	$343M	Sell	6,455,339 -240,101	-4%	-$12.2M	0.32%	79
2013 Q3	$310M	Buy	6,695,440 +3,660,604	+121%	+$161M	0.31%	84
2013 Q2	$136M	Buy	+3,034,836	New	+$132M	0.14%	188

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Investors US's BMY Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Bristol-Myers Squibb (BMY) stake by 74% in Q1 2017, selling an estimated $809M and leaving 5,075,397 shares worth $276M. The position accounts for 0.23% of the portfolio, ranked #126.

Janus Henderson Investors US first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.61B in Q2 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Janus Henderson Investors US held 5,075,397 shares of Bristol-Myers Squibb worth $276M as of Q1 2017.
Janus Henderson Investors US sold 14,748,620 Bristol-Myers Squibb shares in Q1 2017, an estimated $809M.
Bristol-Myers Squibb made up 0.23% of Janus Henderson Investors US's portfolio in Q1 2017, its #126 holding.
Janus Henderson Investors US first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
Janus Henderson Investors US's Bristol-Myers Squibb position peaked at $1.61B in Q2 2016.
1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.